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Background: Several recent studies have described increasing rates of unilateral and bilateral mastectomy among
women with newly diagnosed breast cancer. The use of breast magnetic resonance imaging (MRI) has also risen rapidly,
leading to speculation that the high false-positive rate and need for multiple biopsies associated with MRI may contribute
to more mastectomies. The objective of this study was to determine whether newly diagnosed patients who underwent
preoperative MRI were more likely to undergo mastectomy compared with those who did not have a preoperative MRI.
Methods: A retrospective review was performed of all newly diagnosed patients with breast cancer at our academic
breast center from 2004 to 2009.
Results: The proportion of newly diagnosed patients with breast cancer having MRI prior to surgery increased from 6% in
2004 to 73% in 2009. Of 628 patients who underwent diagnostic MRI, 369 (59%) had abnormal results, 257 (41%) had one
or more biopsies, and 73 had additional sites of cancer diagnosed. Patients with a malignant biopsy, or those with an
abnormal MRI who did not undergo biopsy, had an increased mastectomy rate (P<0.01). However, patients with a normal
MRI or a benign biopsy actually had a decreased mastectomy rate (P<0.05). Although there was a trend toward more
bilateral mastectomies, the overall mastectomy rate did not change over this time period.
Conclusions: Although there is a strong relationship between the result of an MRI and the choice of surgery, the overall
effect is not always to increase the mastectomy rate. Some patients who were initially considering mastectomy chose
lumpectomy after an MRI.Background
Carefully conducted randomized controlled trials have
shown no significant difference in either overall survival
or local recurrence for women who undergo mastectomy
versus those who elect to have breast conservation sur-
gery (BCT) followed by radiation therapy for the treat-
ment of early-stage breast cancer [1]. Based on these
findings, mastectomy rates had been declining over the
past 3 decades in favor of BCT [2], but within the past
several years both unilateral and bilateral mastectomy
rates have begun to rise [3,4]. Several reasons for this
observed increase have been proposed, including ex-
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reproduction in any medium, provided the orgenetic mutations, advances in post-mastectomy breast
reconstruction, increased public awareness and height-
ened patient anxiety, and the more liberal use of pre-
operative breast magnetic resonance imaging (MRI).
However, there are few data with which to evaluate the
significance of these proposed etiologies.
Currently, breast MRI is often used in newly diagnosed
patients with breast cancer to evaluate the extent of dis-
ease and look for additional foci of mammographically
occult lesions in the affected breast, and to examine the
contralateral breast. However, because MRI is a very
sensitive test, the false-positive rate for detected lesions
is high, leading to an increased number of image-guided
biopsies before definitive surgery. Nonetheless, MRI does
detect mammographically occult disease in the ipsilateral
breast in 11 to 31%, of patients [5] and in the contralateral
breast in 3 to 4% [6]. Although these lesions are usually
relatively small when they are detected, surgical treatment
planning can be affected. Based on the extent of diseaseLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Patient and tumor characteristics
MRI (n = 628) No MRI (n = 817) P-value
Age, years
Mean 53 60 <0.001
<50 43% 26% <0.001
>50 56% 73% <0.001
Ethnicity
Asian 3% 2% NS
Black 8% 12% NS
Hispanic 6% 4% NS
White 78% 79% NS
Other/unknown 5% 3% NS
Stage
0 23% 27% 0.08
1 39% 39% NS
2 29% 22% NS
3 7% 8% NS
4 2% 3% NS
Tumor size (cm) 1.6 1.5 NS
Histology
DCIS 24% 26% NS
Infiltrating ductal 59% 53% NS
Infiltrating lobular 12% 11% NS
Other 5% 10% NS






























Figure 1 Magnetic resonance imaging (MRI) use and definitive
surgery over time.
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lumpectomy or mastectomy; however, for the majority of
patients in whom no additional lesions are found,
management remains unchanged. Whether or not this
increased rate of detection of small foci of disease will
ultimately lead to improvements in the local recurrence
rate and/or mortality rate remains to be determined.
The purpose of this study was to characterize the
increased use of preoperative breast MRI at our institution
over a 6 year period, and to investigate whether patients
who underwent a preoperative breast MRI were more
likely to ultimately have a mastectomy than those who did
not undergo MRI.
Methods
Using a prospectively maintained database, all newly diag-
nosed patients with breast cancer who were treated at the
Yale New Haven Breast Center from 2004 to 2009 were
identified. Patients who did not receive definitive breast
surgery during the study period because of distant metas-
tases or neoadjuvant chemotherapy were excluded. Patient
and tumor characteristics, imaging and biopsy findings,
surgical treatment, and final pathology results were
recorded. Yearly mastectomy rates were determined and
compared with BCT rates across the 6 year period.
This was a retrospective chart review and was
approved by the Yale University IRB as exempt.
Patients who underwent preoperative breast MRI were
identified. MRI was performed at the discretion of the
treating breast surgeon. Those with additional suspicious
lesions were identified, and biopsy results were obtained.
Operative, imaging, and pathology reports were reviewed
and compared with data in the clinical chart for
accuracy.
Statistical analysis
Statistical analysis was performed using SPSS statistical
software (SPSS Inc., Chicago, IL, USA). Categorical data
were compared with χ2 tests and means of continuous
data were compared with t-tests. Multivariable analysis
was performed with logistic regression. All significance
testing was two-sided.
Results
In total, 1,445 patients with newly diagnosed breast can-
cer had definitive breast surgery at the Yale New Haven
Breast Center from 2004 to 2009. Of this group, 628 pa-
tients (43%) underwent diagnostic MRI. Patient and
tumor characteristics for the two groups are presented
in Table 1. The mean age for those patients who under-
went breast MRI was 53 years and the mean age for
those who did not was 60 years (P<0.001) There was no
significant difference in ethnicity, tumor stage, tumor
histology or mean tumor size between the two groups.The use of preoperative MRI increased sharply over
the study period, from 6% of newly diagnosed patients
with breast cancer in 2004 to 73% in 2009. The rates of
lumpectomy and unilateral mastectomy declined slightly
over this period, whereas the rate of bilateral mastec-
tomy increased (Figure 1).
The relationship between the type of breast surgery
performed and MRI usage is shown in Table 2. The
Table 2 Surgical treatment for those who had definitive
surgery
Type of surgery MRI (n = 628) No MRI (n = 817) P-value
Partialmastectomy 355 (57%) 504 (62%) 0.06
Unilateralmastectomy 147 (23%) 211 (26%) NS
Bilateralmastectomy 123 (20%) 102 (12%) <0.005
Abbreviations: MRI magnetic resonance imaging, NS non-significant.
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study period was 355 (57%) in the group who underwent
preoperative MRI and 504 (62%) in the group who did
not (P = 0.06). Thus MRI was associated with a non-
significant trend toward a lower lumpectomy rate.
There was no significant difference between the two
groups with regard to unilateral mastectomy (23% and
26%, respectively), but the number of bilateral mastecto-
mies performed was significantly higher in the group
that underwent preoperative MRI (123 (20%) versus 102
(12%), P<0.005).
Table 3 shows some of the outcomes associated with the
use of MRI. Of 628 patients who underwent preoperative
breast MRI, 369 (59%) had abnormal results: 29% on the
ipsilateral side, 12% on the contralateral side, and 18% in
both breasts. In total, 257 patients (41%) underwent one
or more biopsies. Most often, targeted ultrasound with
image-guided core biopsy was attempted before MRI
guided biopsy. Malignant results were documented by
biopsy results in the ipsilateral breast in 52 cases (8%), the
contralateral breast in 15 (2%), and both in 6 (1%).Table 3 Surgical treatment according to the results of
magnetic resonance imaging (MRI)




No MRI 817 62% 26% 12%
MRI
Normal 259 66% 17%c 16%
Abnormal
Ipsilateral 182 51%c 34%c 15%
Contralateral 73 53% 21% 26%c
Both 114 46%c 23% 31%c
MRI biopsya
None 132 39%c 35%c 26%c
Benign 184 66% 21% 13%
Malignant
Ipsilateralb 52 35%c 38%c 27%c
Contralateral 15 33%c 0c 67%c
Both 6 0c 0 100%c
aFor those with abnormal MRI.
bIn addition to index lesion.
cP<0.05 compared with the rate for the same surgery with no MRI.The outcome of the MRI strongly influenced the
choice of surgery compared with the group that did not
undergo MRI. As might be expected, a diagnosis of a
second ipsilateral or contralateral malignancy was
associated with a decreased lumpectomy rate and an
increase in the rates of unilateral and bilateral mastec-
tomy. However, the group that had an abnormal MRI
and did not undergo biopsy also had a lumpectomy rate
of only 39%, and the rates of unilateral and bilateral
mastectomy were 35% and 26%, respectively. We were
not able to determine how many of these women chose
mastectomy to avoid another needle biopsy. Although
not significant, when compared with the women who
did not have an MRI, the women with a normal MRI or
a benign biopsy actually had an increased lumpectomy
rate (66% and 62%). Thus, some women who were
considering mastectomy may have chosen lumpectomy
based on the MRI results. This may explain why the use
of MRI had a relatively modest effect overall on the
lumpectomy rate.
Because young women were more likely to receive an
MRI and also more likely to choose bilateral mastec-
tomy, a multivariable logistic regression model was
constructed with age, stage, and MRI use. As seen in
Table 4, both young age and MRI use were indepen-
dently associated with an increased rate of bilateral
mastectomy.
Discussion
The use of preoperative MRI in patients with newly
diagnosed breast cancer is controversial. Proponents of
the test are supported by studies showing that breast
MRI detects mammographically occult disease in both
the ipsilateral and the contralateral breast, has overall
sensitivity rates ranging from 73 to 94%, and has a
positive predictive value ranging anywhere from 24 to
89% [7-11]. There is speculation that better preoperative
imaging with MRI may lead to decreased numbers of
patients with positive margins, and thus lower recur-
rence rates and ultimately improved overall survival,
although to date these data are conflicting [12,13].Table 4 Multivariable logistic regression for bilateral
mastectomy
Characteristic OR (95% CI) P value
Age
Over 50 Reference
Under 50 3.47 (2.57 to 4.70) < 0.001
MRI use
No Reference
Yes 1.38 (1.02 to 1.87) 0.036
Abbreviations: CI confidence interval, MRI magnetic resonance imaging,
OR odds ratio.
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designed to show a difference in these outcome
measures would require large numbers to achieve statis-
tical significance and long term follow-up to detect
recurrence rates, and may be difficult to perform.
On the other hand, preoperative breast MRI has been
criticized for several reasons. These include but are not
limited to: delays in surgical management, an unaccep-
tably high false-positive rate, increased costs associated
with the test itself and with additional biopsies, heightened
patient anxiety, and unnecessary changes in surgical ma-
nagement to avoid additional biopsy and/or the perceived
risk of a future recurrence. Although individual studies
vary, a recent review by Houssami and Hayes reported
that, based on pooled estimates from meta-analyses,
preoperative breast MRI led to more extensive surgery in
11.3% of patients, including wider resection or mastec-
tomy, and that 8.1% of all women eligible for BCT were
treated with mastectomy because of MRI-only detection
of additional disease [14].
Nonetheless, the use of preoperative breast MRI has
gained momentum in the surgical community. Although
its use varies by geographic region, up to 74% of all
breast imaging centers offer the test [15]. Thus, it
appears that the selective use of preoperative breast MRI
is increasingly being used to guide clinical decision-
making for newly diagnosed patients. Our data support
this trend. Over the study period, there was an increase
in both the percentage of newly diagnosed patients who
underwent preoperative MRI and the percentage of
patients who underwent biopsy for MRI-detected
lesions. Although we may still be on the steep portion of
the learning curve with regard to the characterization of
suspicious lesions seen on MRI, addressing the low
specificity of MRI is certainly an area for which further
research is warranted. In addition, whether these
additional areas might ever become clinically signifi-
cant, especially among older patients and patients
undergoing post-operative radiation therapy, remains
an area of debate.
The observed increase in the utilization of preopera-
tive breast MRI and a concurrent rise in the number of
unilateral and bilateral mastectomies performed over the
past several years have led researchers to wonder if the
two events are related. Several recent studies have
reported increasing rates of contralateral prophylactic
mastectomy, especially among younger, highly educated
patients, and those with a positive family history
[4,16-18]. Although this phenomenon does coincide with
the adoption of preoperative breast MRI, it is not yet
clear whether the relationship is one of cause and effect.
In the present study, BCT rates did decrease slightly
over the study period in favor of mastectomy, going
from 60% in 2004 to 54% in 2009, but the use ofpreoperative MRI increased much more sharply.
Interestingly, the highest BCT rates of any group
were among patients with a normal MRI, (66%), even
compared with those who did not undergo MRI. Per-
haps an MRI scan that does not show any additional
suspicious findings can help guide patients who are
interested in pursuing BCT.
In a recent editorial, Tuttle asked whether patients
with abnormal MRI findings and biopsy on the contra-
lateral side might be more inclined to undergo bilateral
mastectomy than those who did not [19]. In our study,
we examined this question, and found that this was
indeed the case. The greatest difference with regard to
definitive surgical management was in the type of mastec-
tomy performed that is, unilateral versus bilateral. In
2004, 15% (n = 20) of patients underwent bilateral mastec-
tomy, but by 2009, 27% of patients (n = 56) underwent
bilateral mastectomy. During the same period, the use of
preoperative MRI increased from 6% to 73%. Compared
with other treatment options, those who underwent
bilateral mastectomy were more likely to have had a
contralateral biopsy-proven malignancy based on MRI
findings. Although abnormal breast MRI findings may
have influenced the decision to undergo bilateral mastec-
tomy, it is probable that there are a host of factors that
affect the choice of definitive surgery for any given patient.
It is likely that physician recommendations, patient age,
family history, genetic testing, and reconstruction options
all play a role.
Conclusion
In summary, we found a dramatic increase in the use of
preoperative breast MRI among newly diagnosed patients
with breast cancer over the 6 year period of the study. A
preoperative MRI that revealed only the known cancer, or
that led to a benign biopsy, was associated with a higher
rate of BCT over mastectomy. Thus, although there is a
strong relationship between the result of the MRI and the
choice of surgery, the overall effect is not always to
increase the mastectomy rate.
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